Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for C&R Research Inc. (359090:KRX), powered by AI.
C&R Research Inc. is currently trading at ₩550. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for C&R Research Inc. on Alpha Lenz.
C&R Research Inc.'s P/E ratio is 2.4.
“C&R Research Inc. trades at a P/E of 2.4 (undervalued) with modest ROE of 5.4%. 3Y revenue CAGR of 10.3% highlights clear growth momentum.”
Ask for details →C&R Research Inc. is a company specializing in providing insights and analytics services focused on consumer behavior and market research. Its primary function is to deliver detailed research reports and data-driven insights to help various industries understand market trends and consumer demand. C&R Research serves sectors including retail, healthcare, financial services, and technology, offering tailored solutions that guide product development, marketing strategies, and customer engagement efforts. Through its innovative research methodologies, C&R Research Inc. plays a crucial role in informing business executives and decision-makers. The company is especially significant in the retail sector, where companies rely on its expertise to anticipate shifts in consumer preferences and behaviors. Positioned uniquely within the market research industry, C&R Research helps its clients adapt and thrive in competitive markets by providing actionable intelligence that supports strategic planning and operational enhancements.
“C&R Research Inc. trades at a P/E of 2.4 (undervalued) with modest ROE of 5.4%. 3Y revenue CAGR of 10.3% highlights clear growth momentum.”
Ask for details →C&R Research Inc. (ticker: 359090) is a company listed on KRX in the Healthcare sector (Health Information Services). It has approximately 505 employees. Market cap is $6.3B.
The current price is ₩550 with a P/E ratio of 2.45x and P/B of 0.13x.
ROE is 5.37% and operating margin is 2.13%. Annual revenue is $65.0B.